FR2551M - Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia. - Google Patents

Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.

Info

Publication number
FR2551M
FR2551M FR928068A FR928068A FR2551M FR 2551 M FR2551 M FR 2551M FR 928068 A FR928068 A FR 928068A FR 928068 A FR928068 A FR 928068A FR 2551 M FR2551 M FR 2551M
Authority
FR
France
Prior art keywords
oxazolinone
asthenia
phenyl
amino
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR928068A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DAUSSE LAB
Original Assignee
DAUSSE LAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DAUSSE LAB filed Critical DAUSSE LAB
Priority to FR928068A priority Critical patent/FR2551M/en
Application granted granted Critical
Publication of FR2551M publication Critical patent/FR2551M/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR928068A 1963-03-15 1963-03-15 Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia. Expired FR2551M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR928068A FR2551M (en) 1963-03-15 1963-03-15 Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR928068A FR2551M (en) 1963-03-15 1963-03-15 Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.

Publications (1)

Publication Number Publication Date
FR2551M true FR2551M (en) 1964-05-25

Family

ID=8799291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR928068A Expired FR2551M (en) 1963-03-15 1963-03-15 Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.

Country Status (1)

Country Link
FR (1) FR2551M (en)

Similar Documents

Publication Publication Date Title
DK106814C (en) Polish suitable for use in dental care products.
NL144526B (en) RASP.
NL156055B (en) BLOOD TREATMENT DEVICE.
AT255640B (en) Standard dental device
FR1397535A (en) Diffused alloy transistor
OA00339A (en) Composition for hair treatment.
BE749334A (en) TREATMENT DEVICE
FR2526M (en) Pyrocatechol-0-methyltransferase inhibitor drug.
OA00595A (en) Activation device.
FR2944M (en) Medicine for the treatment of cough based on 2-amino-6-methylheptane.
FR2551M (en) Medicinal product based on (+) 5-phenyl-2-amino oxazolinone-4 intended in particular for the treatment of asthenia.
OA01035A (en) New substituted coumarins and their preparation methods.
FR3414M (en) (2 'thienyl) - 1 oxo-1 2 amino propanes and pharmaceutical compositions.
FR2108854A1 (en) MACHINING PARTS EXTRACTION DEVICE
CH555656A (en) DEVICE FOR TREATMENT OF HAIR.
NL144745B (en) CARD EJECTOR.
CH400407A (en) EDM machining device
DK106635C (en) Dental care product.
DK103735C (en) Dental care product.
FR2690M (en) Methoxy-3α-methyl-17α 5 & alpha-androstanol-17β.
FR1358659A (en) Device for hair treatment
FR26F (en) Medicinal product based on an amino oxazolinone derivative, intended, in particular, for the treatment of asthenia.
FR1243M (en) Medicinal product based on an amino oxazolinone derivative intended, in particular, for the treatment of asthenia.
FR1385263A (en) Improvements in the treatment of metal surfaces
FR1390897A (en) Cleaning device, in particular for shoes